0000891293-16-000163.txt : 20160520 0000891293-16-000163.hdr.sgml : 20160520 20160520165826 ACCESSION NUMBER: 0000891293-16-000163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160518 FILED AS OF DATE: 20160520 DATE AS OF CHANGE: 20160520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIANCO JAMES A CENTRAL INDEX KEY: 0001198554 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 161666994 FORMER NAME: FORMER CONFORMED NAME: BLANCO JAMES A DATE OF NAME CHANGE: 20021015 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-05-18 0 0000891293 CTI BIOPHARMA CORP ctic 0001198554 BIANCO JAMES A 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 1 1 0 0 President and CEO Employee Stock Opyion (Right to Buy) 0.4475 2016-05-18 4 A 0 600000 0 A 2026-05-18 Common Stock 600000 600000 D The option vests 12.5% beginning on July 7, 2016 and vests an additional 12.5% every 6 months thereafter, with the final vesting on January 7, 2020, in each case subject to the reporting person's continued employment or service with the issuer through the applicable vesting date. The option can only be exercised if CTI's stock is trading at or above $1.20. By: Louis A. Bianco, Attorney-in-fact For: James A. Bianco 2016-05-20